iTeos Therapeutics stockholders elect all Class II director nominees and ratify auditor at annual meeting

iTeos Therapeutics, Inc.

Quorum of 87.67% achieved with 33,554,964 shares voting at June 17 annual meeting.
Tony Ho elected with 21,907,643 votes for; Robert Iannone with 24,909,798; Ann D. Rhoades with 20,985,311.
Ratification of Deloitte Bedrijfsrevisoren as auditor approved: 33,347,344 for, 24,081 against, 183,538 abstain.
No other matters were voted on at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.